| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 1403898-55-4 | AT-IAP |
≥98% | | 询价 |
| 2 | 63951-14-4 | Ammonium,(6-(p-triethylammoniophenyl)hexyl)triethyl-,diiodide |
≥98% | | 询价 |
| 3 | 1133378-83-2 | Tafenoquine-d3 succinate |
≥98% | | 询价 |
| 4 | | Methylscopolamine |
≥98% | | 询价 |
| 5 | 124832-27-5 | Valacyclovir HCl |
≥98% | | 询价 |
| 6 | 13539-59-8 | Azapropazone |
≥98% | | 询价 |
| 7 | 104691-86-3 | Lupiwighteone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 1009119-83-8 | HCV-IN-29 |
≥98% | | 询价 |
| 9 | 1613458-70-0 | GSK-2793660 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 10 | 557766-15-1 | 4-Aza-Oleanolic acid methyl ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 133033-93-9 | (±)-Darifenacin |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | | Glycerol phenylbutyrate-D15 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 13 | | ICA-105665 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 1597426-52-2 | T-448 free base |
≥98% | | 询价 |
| 15 | | DBCO-PEG4-Ahx-DM1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 16 | 1417700-13-0 | ML188 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 17 | | DM1-PEG4-DBCO |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 1613191-99-3 | Gartisertib(M4344 VX-803 ATR inhibitor 2) |
≥98% | | 询价 |
| 19 | 1992052-49-9 | SI-2 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 20 | 2387505-78-2 | Calhex 231 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 21 | 13116-77-3 | NSC624206 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 22 | 2321366-46-3 | Nω-Propyl-L-arginine HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | 2250019-91-9 | CRT0066854 |
≥98% | | 询价 |
| 24 | 1242422-09-8 | SSTC3 |
≥98% | | 询价 |
| 25 | 2168525-92-4 | UT-34 |
≥98% | | 询价 |
| 26 | 1007882-23-6 | HCV-IN-30 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | | Angiotensinogen(1-14),human TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 151-18-8 | β-Aminopropionitrile |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 29 | 4593-90-2 | 3-Phenylbutyric acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | | Frakefamide TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 13441-51-5 | D-Kynurenine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 13679-70-4 | 5-Methyl-2-thiophenecarboxaldehyde |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | | Glycerol phenylbutyrate-D5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | | CALP3 TFA |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | 261969-05-5 | CALP3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 6027-13-0 | L-Homocysteine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 93755-77-2 | Avenanthramide E |
≥98% | | 询价 |
| 38 | 72766-92-8 | Actinomycin D1 |
≥98% | | 询价 |
| 39 | 91833-49-7 | Rocastine |
≥98% | | 询价 |
| 40 | 851510-67-3 | ASP-4000 free base |
≥98% | | 询价 |
| 41 | 404009-46-7 | AMA-37 |
≥98% | | 询价 |
| 42 | 66564-14-5 | Cinitapride |
≥98% | | 询价 |
| 43 | 134867-98-4 | AWD-G256 |
≥98% | | 询价 |
| 44 | 734542-09-7 | RU-0207148 |
≥98% | | 询价 |
| 45 | 1007573-18-3 | GSK-1521498 |
≥98% | | 询价 |
| 46 | 350992-13-1 | Bifeprunox Mesylate |
≥98% | | 询价 |
| 47 | 1220-83-3 | Sulfamonmethoxine |
≥98% | | 询价 |
| 48 | 878983-38-1 | AKOS-22 |
≥98% | | 询价 |
| 49 | 22195-34-2 | Guanadrel Sulfate |
≥98% | | 询价 |
| 50 | 4981-83-3 | Benzyl-PEG2-Tos |
≥98% | | 询价 |
| 51 | 691868-88-9 | RO8191 |
≥98% | | 询价 |
| 52 | 130273-87-9 | Bimatoprost isopropyl ester |
≥98% | | 询价 |
| 53 | 107756-30-9 | A61603 Hydrobromide |
≥98% | | 询价 |
| 54 | 1607842-55-6 | Octreotide HCl |
≥98% | | 询价 |
| 55 | 106008-70-2 | Clostomycin B2 |
≥98% | | 询价 |
| 56 | 78-12-6 | Petrichloral |
≥98% | | 询价 |
| 57 | 162870-29-3 | Dihydroxyphenylglycine(anhydrous) |
≥98% | | 询价 |
| 58 | 1380310-94-0 | BAY-721973 |
≥98% | | 询价 |
| 59 | 92358-02-6 | S 25932 |
≥98% | | 询价 |
| 60 | 1216665-49-4 | APY29 |
≥98% | | 询价 |
m.cnreagent.com